Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designs
=================================================================================================================

* Tian Zhang
* Patrick M Forde
* Ryan J Sullivan
* Elad Sharon
* Elizabeth Barksdale
* Wendy Selig
* Scot Ebbinghaus
* Gina Fusaro
* Damla Gunenc
* Dena Battle
* Robyn Burns
* Marc S Hurlbert
* Mark Stewart
* Michael B Atkins